The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Medidata Solutions Named One of Deloitte’s 2012 Technology Fast 500™

November 16, 2012 8:30 am | by The Associated Press | News | Comments

NEW YORK--(BUSINESS WIRE)--Nov 16, 2012--Medidata Solutions (NASDAQ: MDSO), a leading global provider of cloud-based solutions that optimize the efficiency of clinical development, announced that it has been named to Deloitte’s Technology Fast 500 ™ list, a ranking of the 500 fastest growing...

New Total Joint Replacement Registry From Remedy Informatics Aims to Enable Orthopedic Outcomes Research and Improve Quality for Hospitals and Orthopedic Surgery Groups

November 16, 2012 8:17 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Nov. 16, 2012 /- In an effort to improve the quality of research and outcomes for the booming hip and knee arthroplasty market, Remedy Informatics, Inc., the leading provider of registries and research informatics software for Life Science, today announced the availability of RemedyJoint™, a comprehensive Total Joint Replacement (TJR) outcomes registry....

Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast

November 16, 2012 8:17 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 16, 2012 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the 24 th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27. The presentation by Scot...


Powerful Medical Terminology Browser from Intelligent Medical Objects, Inc. (IMO) Now Available to Both Android and iPhone Users

November 16, 2012 8:16 am | by Bio-Medicine.Org | News | Comments

NORTHBROOK, Ill., Nov. 16, 2012 /- Intelligent Medical Objects (IMO), the leading developer of medical terminology solutions for health records systems, announced today the release of The IMO® Terminology Browser for Android phones. Now clinicians and physicians with Android phones can search for medical billing codes with the same convenience and accuracy previously avail...

Revolutionary "Anti-Aging" Compound Touted by Dr. Oz

November 16, 2012 3:28 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Nov. 16, 2012 /- A recent Dr. Oz segment has people scrambling to get their hands on the new human growth hormone-boosting product SeroVital™-hgh, and its manufacturer, SanMedica International™, is scrambling to keep it in stock. "We're thrilled with the response we've gotten since the Dr. Oz show aired," says Chantelle Daines, Media Consultant for SanMedi...

RaySearch Laboratories AB (publ) Interim Report January 1 – September 30, 2012

November 16, 2012 2:01 am | by The Associated Press | News | Comments

STOCKHOLM, Sweden--(BUSINESS WIRE)--Nov 16, 2012--Regulatory News: JANUARY 1 – SEPTEMBER 30, 2012 Net sales for the period amounted to SEK 105.2 M (80.3) Loss after tax of SEK 5.5 M (profit: 10.2) was reported...

Blog: Early bird? Night Owl? Beth Israel says there’s a gene for that

November 16, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Researchers at Beth Israel Deaconess Medical Center say they have found the gene that determines who will be an early bird and who will be a night owl. Much creepier, researchers say this gene can also predict what time of day a person is most likely to die.

Metamark raises $13M in Series B round

November 16, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Two weeks after announcing the resignation of its CEO, Metamark Genetics Inc. in Cambridge has filed for the receipt of $9 million out of a $13 million Series B round of financing which it plans to use for final clinical validation of two prostate cancer prognostic tests.


Cynosure to offer $53M in stock next week

November 16, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cynosure Inc. (Nasdaq: CYNO), a Westford-based developer of laser- and light-based devices for minimally-invasive and non-invasive aesthetic applications, is looking to raise $53 million in a public offering next week for possible future acquisitions.

Hernia Surgical Mesh Implants

November 16, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments

Most hernias are caused by a combination of pressure and an opening or weakness of muscle or connective tissue. The pressure pushes an organ or tissue through the opening or weak spot. Sometimes the muscle weakness is present at birth but more often it...

Radius Health scuttles $62 million IPO

November 16, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Radius Health Inc., a developer of osteoporosis treatments and other women’s health therapies, has shelved plans to go public, withdrawing its registration statement that was filed on February 6.

Retractable Technologies, Inc.’s Unit Sales Jumped in the Third Quarter of 2012

November 15, 2012 5:39 pm | by The Associated Press | News | Comments

LITTLE ELM, Texas--(BUSINESS WIRE)--Nov 15, 2012--Retractable Technologies, Inc. (NYSE MKT: RVP) reported an overall unit sales increase of 54.7% for the third quarter of 2012, compared to the third quarter of 2011. Comparison of Three Months Ended September 30, 2012 and...

Cook notches a U.S. 1st with FDA approval for Zilver PTX peripheral artery DES

November 15, 2012 4:28 pm | by Mass Device | News | Comments

The FDA awards premarket approval to Cook Medical for its Zilver PTX stent, the 1st U.S. market-approved drug-eluting stent indicated for treatment of peripheral artery disease. Cook Medical finally own premarket approval for its Zilver PTX stent, making it the 1st drug-eluting stent approved by the FDA for treatment of peripheral artery disease. The approval comes 1 year after the FDA's Circulatory Systems Devices Panel unanimously recommended approval for the device, which is a self-expanding drug-eluting stent coated in paclitaxel. News Well, Drug-Eluting Stents, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Complianceread more

Syneron to Participate in Two Upcoming Investor Conferences

November 15, 2012 4:15 pm | by The Associated Press | News | Comments

Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Company management is scheduled to participate at two upcoming investor conferences. (Logo: The first conference is the Leerink Swann...

Tornier to Present at the 24th Annual Piper Jaffray Healthcare Conference

November 15, 2012 4:00 pm | by The Associated Press | News | Comments

AMSTERDAM--(BUSINESS WIRE)--Nov 15, 2012--Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company’s Interim President and Chief Executive Officer, and Shawn McCormick,...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.